Please Note:
This profile was automatically generated using 44 references found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 44 references found on the Internet. This information has not been verified. Learn more...
View all 44 references Web References
-
1. www.medicilon-mpi.com
www.medicilon-mpi.com/board_of - [Cached]Published on: 7/21/2008 Last Visited: 7/21/2008
Chun-Lin Chen, PhD, serves as the CEO of Medicilon/MPI Preclinical Research Shanghai.Formally a Staff for Vertex Pharmaceuticals, Dr. Chen co-founded Medicilon in 2004.Dr Chen is a highly published thought leader in the pharmaceutical industry with extensive experience in academia, pharmaceutical, and regulatory evaluation.Dr. Chen received his PhD from Oklahoma State University, and completed postdoctoral training in the United States.He is a Postdoctoral Fellow at the St. Jude Children's Research Hospital and has held numerous leadership positions in professional scientific trade organizations in China as well as other parts of the world. -
2. www.exygenresearch.com
www.exygenresearch.com/print_p - [Cached]Published on: 7/16/2008 Last Visited: 7/16/2008
Contact Person: Chun-Lin Chen, PhD Email: clchen@medicilon.com
...
Chun-Lin Chen, PhD, co-founder of Medicilon, Inc. and Shanghai Medicilon, will serve as the CEO of Medicilon/MPI Preclinical Research Shanghai.Dr. Chen received his PhD from Oklahoma State University, and completed postdoctoral training in the United States.Dr. Chen has held numerous leadership positions in professional scientific trade organizations in China, as well as other parts of the world.
Jintao Zhang, PhD, co-founder and CEO of Shanghai Medicilon, received his PhD from Shanghai Institute of Organic Chemistry and has served in a number of academic and private research institutions in China and the United States.
...
"Pharmaceutical and biotechnology companies around the world will benefit from being able to conduct research cost-effectively in China according to US FDA standards, and market these products worldwide," adds the CEO and board member for Medicilon/MPI Preclinical Research Shanghai, Dr. Chun-Lin Chen. -
3. MPI Research - News Releases
www.fastsys.com/press071219.as - [Cached]Published on: 1/1/2008 Last Visited: 7/6/2008
Contact Person: Chun-Lin Chen, PhD Email: clchen@medicilon.com
MPI Research and Shanghai Medicilon Announce Shanghai-Based Joint Venture
...
Dr. Chun-Lin Chen, co-founder of Medicilon, Inc. as well as Shanghai Medicilon will serve as the CEO of Medicilon-MPI Preclinical Research.Dr Chen is a highly published thoughtleader in the pharmaceutical industry with extensive experience in academia, pharmaceutical, and regulatory evaluation.Dr. Chen received his PhD from Oklahoma State University, and completed post-doctoral training in the United States.Dr. Chen has held numerous leadership positions in professional scientific trade organizations in China as well as other parts of the world.
"On behalf of our entire organization, we are eager to collaborate with such a high-quality preclinical CRO as MPI Research," says Shanghai Medicilon CEO, Dr. Chen.

